These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 2512883)

  • 1. [Physiopathologic basis of the use of thrombolytic agents during the acute phase of myocardial infarction].
    Castaigne A; Duval-Moulin AM; Dubois-Randé JL; Merlet P
    Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():15-20. PubMed ID: 2512883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arterial permeability, objective of thrombolytic therapy].
    Bassand JP; Schiele F; Bernard Y; Anguenot T
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):677-87. PubMed ID: 1530409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of timing of thrombolytic therapy as shown in clinical trials.
    Pepine CJ
    Clin Cardiol; 1990 Aug; 13(8 Suppl 8):VIII12-7. PubMed ID: 2119925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Should inferior myocardial infarction be thrombolysed?].
    Tabone X; Vacheron A
    Arch Mal Coeur Vaiss; 1992 Apr; 85(4):449-52. PubMed ID: 1642506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis for acute myocardial infarction: drug review.
    Cundiff DK
    MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods for evaluating thrombolytic drugs].
    Castaigne A; Duval-Moulin AM; Dubois-Randé JL; Merlet P
    Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():9-14. PubMed ID: 2108647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytic treatment of myocardial infarction. Data on the limitation of infarction size and left ventricular function].
    Barraud P; Marcaggi X; Boueyre M; Schandrin C; Regeard E; Maublant J; Lusson JR; Cassagnes J
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):689-95. PubMed ID: 1530410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy.
    Roberts R
    Circulation; 1989 Dec; 80(6 Suppl):IV93-101. PubMed ID: 2513147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombolytic therapy in acute myocardial infarct].
    von Essen R
    Z Gesamte Inn Med; 1987 Sep; 42(17):486-91. PubMed ID: 3120430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient reperfusion preferences in acute myocardial infarction: mortality versus stroke, benefits versus costs, high technology versus drugs.
    Tsui W; Pierre K; Massel D
    Can J Cardiol; 2005 Apr; 21(5):423-31. PubMed ID: 15861260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late thrombolysis in the therapy of acute myocardial infarct: the prospects for its wide-spread clinical use].
    Chiariello M; Villari B
    Cardiologia; 1991 Dec; 36(12 Suppl 1):435-41. PubMed ID: 1841799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
    Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
    Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus late opening of coronary arteries: the effect of timing.
    Rapaport E
    Clin Cardiol; 1990 Aug; 13(8 Suppl 8):VIII18-22. PubMed ID: 2145108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prehospital thrombolytic therapy of acute myocardial infarct].
    Tebbe U; Carlsson J
    Herz; 1994 Dec; 19(6):303-13. PubMed ID: 7843687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in reperfusion therapy for acute myocardial infarction.
    Morgan CD
    Can J Cardiol; 1995 May; 11(5):435-40. PubMed ID: 7750041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
    Kobusiak-Prokopowicz M; Mysiak A
    Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heart.
    Schwarz ER; Tussing T; Skobel E; Klosterhalfen B; Domanski D; Fuess JE
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):215-21. PubMed ID: 19605571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.